The Nomination Committee of Sobi has now been appointed in accordance with the AGM resolutions.
AP4 is represented by Thomas Ehlin.
The other members in the committee is:
- Petra Hedengran, Investor
- Lennart Francke, Swedbank Robur Fonder AB
- Håkan Björklund, Chairman of the Board of Swedish Orphan Biovitrum AB
Sobi is an international speciality healtcare company dedicated to rare diseases. Sobi's mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Heamophilia, Inflammation and Genetic diseases. The share (STO:SOBI) is listed on Nasdaq Stockholm.